RARE
Price
$36.52
Change
-$0.91 (-2.43%)
Updated
Jun 27 closing price
Capitalization
3.45B
33 days until earnings call
RNA
Price
$29.03
Change
-$0.80 (-2.68%)
Updated
Jun 27 closing price
Capitalization
3.5B
45 days until earnings call
Interact to see
Advertisement

RARE vs RNA

Header iconRARE vs RNA Comparison
Open Charts RARE vs RNABanner chart's image
Ultragenyx Pharmaceutical
Price$36.52
Change-$0.91 (-2.43%)
Volume$2.68M
Capitalization3.45B
Avidity Biosciences
Price$29.03
Change-$0.80 (-2.68%)
Volume$1.31M
Capitalization3.5B
RARE vs RNA Comparison Chart in %
Loading...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RARE vs. RNA commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RARE is a Hold and RNA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (RARE: $36.51 vs. RNA: $29.03)
Brand notoriety: RARE and RNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RARE: 259% vs. RNA: 88%
Market capitalization -- RARE: $3.45B vs. RNA: $3.5B
RARE [@Biotechnology] is valued at $3.45B. RNA’s [@Biotechnology] market capitalization is $3.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RARE’s FA Score shows that 0 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • RARE’s FA Score: 0 green, 5 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, RARE is a better buy in the long-term than RNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RARE’s TA Score shows that 4 TA indicator(s) are bullish while RNA’s TA Score has 3 bullish TA indicator(s).

  • RARE’s TA Score: 4 bullish, 6 bearish.
  • RNA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, RARE is a better buy in the short-term than RNA.

Price Growth

RARE (@Biotechnology) experienced а -1.70% price change this week, while RNA (@Biotechnology) price change was -0.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

RARE is expected to report earnings on Jul 31, 2025.

RNA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNA($3.5B) and RARE($3.45B) have the same market capitalization . RNA YTD gains are higher at: -0.172 vs. RARE (-13.216). RNA (-430.35M) and RARE (-449.9M) have comparable annual earnings (EBITDA) . RNA has more cash in the bank: 1.38B vs. RARE (494M). RNA has less debt than RARE: RNA (5.97M) vs RARE (38.3M). RARE has higher revenues than RNA: RARE (591M) vs RNA (8.93M).
RARERNARARE / RNA
Capitalization3.45B3.5B99%
EBITDA-449.9M-430.35M105%
Gain YTD-13.216-0.1727,687%
P/E RatioN/AN/A-
Revenue591M8.93M6,620%
Total Cash494M1.38B36%
Total Debt38.3M5.97M641%
FUNDAMENTALS RATINGS
RARE: Fundamental Ratings
RARE
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RARERNA
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IFRA49.150.28
+0.57%
iShares US Infrastructure ETF
QQQH52.300.15
+0.29%
NEOS Nasdaq-100 Hdg Eq Inc ETF
SWAN30.380.04
+0.15%
Amplify BlackSwan Gr & Trsry Cor ETF
DMA8.700.01
+0.12%
Destra Multi-Alternative Fund
PEO21.46-0.03
-0.14%
Adams Natural Resources Fund